LitCovid-sample-Enju  

PMC:7199903 / 3755-4124 JSONTXT 15 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T610 4-7 DT denotes the
T611 8-14 NN denotes glycan
T612 15-25 NN denotes maturation
T613 26-33 NN denotes pathway
T614 35-43 JJ denotes Impaired
T615 44-50 NN denotes glycan
T616 51-61 NN denotes maturation
T617 62-71 VBG denotes resulting
T618 72-74 IN denotes in
T619 75-78 DT denotes the
T620 79-87 NN denotes presence
T621 88-90 IN denotes of
T622 91-108 JJ denotes oligomannose-type
T623 109-116 NNS denotes glycans
T624 117-120 MD denotes can
T625 121-123 VB denotes be
T626 124-125 DT denotes a
T627 126-135 JJ denotes sensitive
T628 136-144 NN denotes reporter
T629 145-147 IN denotes of
T630 148-159 JJ denotes native-like
T631 160-167 NN denotes protein
T632 168-180 NN denotes architecture
T633 181-182 -LRB- denotes (
T634 182-183 CD denotes 8
T635 183-184 -RRB- denotes )
T636 184-185 -COMMA- denotes ,
T637 186-189 CC denotes and
T638 190-203 JJ denotes site-specific
T639 204-210 NN denotes glycan
T640 211-219 NN denotes analysis
T641 220-223 MD denotes can
T642 224-226 VB denotes be
T643 227-231 VBN denotes used
T644 232-234 TO denotes to
T645 235-242 VB denotes compare
T646 243-252 JJ denotes different
T647 253-263 NNS denotes immunogens
T648 264-267 CC denotes and
T649 268-275 NN denotes monitor
T650 276-289 NN denotes manufacturing
T651 290-299 NNS denotes processes
T652 300-301 -LRB- denotes (
T653 301-303 CD denotes 18
T654 303-304 -RRB- denotes )
T655 306-318 RB denotes Additionally
T656 318-319 -COMMA- denotes ,
T657 320-333 NN denotes glycosylation
T658 334-337 MD denotes can
T659 338-347 VB denotes influence
T660 348-351 DT denotes the
T661 352-363 NN denotes trafficking
T662 364-366 IN denotes of
R610 T613 T610 arg1Of pathway,the
R611 T613 T611 arg1Of pathway,glycan
R612 T613 T612 arg1Of pathway,maturation
R613 T616 T614 arg1Of maturation,Impaired
R614 T616 T615 arg1Of maturation,glycan
R615 T616 T617 arg1Of maturation,resulting
R616 T617 T618 arg1Of resulting,in
R617 T620 T618 arg2Of presence,in
R618 T620 T619 arg1Of presence,the
R619 T620 T621 arg1Of presence,of
R620 T623 T621 arg2Of glycans,of
R621 T623 T622 arg1Of glycans,oligomannose-type
R622 T616 T624 arg1Of maturation,can
R623 T625 T624 arg2Of be,can
R624 T616 T625 arg1Of maturation,be
R625 T628 T625 arg2Of reporter,be
R626 T628 T626 arg1Of reporter,a
R627 T628 T627 arg1Of reporter,sensitive
R628 T628 T629 arg1Of reporter,of
R629 T632 T629 arg2Of architecture,of
R630 T632 T630 arg1Of architecture,native-like
R631 T632 T631 arg1Of architecture,protein
R632 T632 T633 arg1Of architecture,(
R633 T634 T633 arg2Of 8,(
R634 T635 T633 arg3Of ),(
R635 T637 T636 arg1Of and,","
R636 T625 T637 arg1Of be,and
R637 T643 T637 arg2Of used,and
R638 T640 T638 arg1Of analysis,site-specific
R639 T640 T639 arg1Of analysis,glycan
R640 T640 T641 arg1Of analysis,can
R641 T643 T641 arg2Of used,can
R642 T640 T642 arg1Of analysis,be
R643 T643 T642 arg2Of used,be
R644 T640 T643 arg2Of analysis,used
R645 T645 T643 arg3Of compare,used
R646 T645 T644 arg1Of compare,to
R647 T640 T645 arg1Of analysis,compare
R648 T648 T645 arg2Of and,compare
R649 T647 T646 arg1Of immunogens,different
R650 T647 T648 arg1Of immunogens,and
R651 T651 T648 arg2Of processes,and
R652 T651 T649 arg1Of processes,monitor
R653 T651 T650 arg1Of processes,manufacturing
R654 T651 T652 arg1Of processes,(
R655 T653 T652 arg2Of 18,(
R656 T654 T652 arg3Of ),(
R657 T659 T655 arg1Of influence,Additionally
R658 T659 T656 arg1Of influence,","
R659 T657 T658 arg1Of glycosylation,can
R660 T659 T658 arg2Of influence,can
R661 T657 T659 arg1Of glycosylation,influence
R662 T661 T659 arg2Of trafficking,influence
R663 T661 T660 arg1Of trafficking,the
R664 T661 T662 arg1Of trafficking,of